StockData
Astrana Health, Inc. logo

Astrana Health, Inc. (ASTH) shareholders

ASTHNasdaqServices-Management Consulting ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/307% below fair value
$31.80+0.03 (+0.09%)

Close on Nov 13, 2026Market cap $1.77BP/E 29.7Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
57.7%
32M of 56M shares
Institutional holders
209
58 new, 17 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BlackRock, Inc.6,234,44612.40%13G (passive) amendmentMar 31, 2025
Allied Physicians of California, a Professional Medical Corporation6,132,80211.00%13D (active) amendmentFeb 15, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ASTHValueChange% of portfolio
BlackRock, Inc.6,899,99012.38%$320.23M+736,2630.00%
Vanguard Portfolio Management LLC2,605,7754.68%$120.93M+328,9690.01%
Vanguard Capital Management LLC1,946,4313.49%$90.33M+236,1690.00%
State Street Corp1,738,9303.12%$80.70M+88,4400.00%
325 Capital LLC1,613,8432.90%$74.90M−225,23317.85%
Dimensional Fund Advisors LP1,468,5082.63%$68.15M+100,4290.01%
Wellington Management Group Llp1,292,5732.32%$59.99M−49,2510.01%
Geode Capital Management, LLC1,167,9742.10%$54.22M+129,8890.00%
Bank Of America Corp /De/852,1451.53%$39.55M+277,4160.00%
FMR LLC685,9221.23%$31.83M+269,7970.00%
Wells Fargo & Company/Mn664,9401.19%$30.86M+561,9410.00%
Charles Schwab Investment Management Inc652,6691.17%$30.29M+8,4980.00%
Ameriprise Financial Inc512,1100.92%$23.77M−39,4890.00%
Northern Trust Corp505,0440.91%$23.44M+66,8810.00%
Diamond Hill Capital Management Inc475,9410.85%$22.09M−68,0930.18%
Royce & Associates LP472,4800.85%$21.93M+75,5190.18%
SteelPeak Wealth, LLC464,9370.83%$21.58M−95,0000.56%
Morgan Stanley433,5080.78%$20.12M+94,7050.00%
Invesco Ltd.381,8300.69%$17.72M+30,7180.00%
Vanguard Fiduciary Trust Co307,0220.55%$14.25M+14,0190.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202620932M57.7%58 / 8149 / 175M3M
Q1 202617130M53.7%27 / 6454 / 287M2M
Q4 202517629M52.3%38 / 5666 / 434M2M
Q3 202518827M48.1%48 / 6556 / 213M2M
Q2 202516226M46.8%32 / 5355 / 352M2M
Q1 202516826M47.0%21 / 5859 / 312M2M
Q4 202417926M46.8%31 / 6854 / 413M2M
Q3 202418925M45.5%32 / 6958 / 1410M1M
Q2 202417223M41.5%30 / 6448 / 152M2M
Q1 202415924M42.3%28 / 5051 / 121M1M
Q4 202314323M40.7%22 / 4751 / 122M1M
Q3 202313422M38.6%16 / 5246 / 121M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

216 funds held ASTH in Q2 2026, 70% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of ASTHValue% of fundAs of
iShares Core S&P Small-Cap ETF2,558,0154.59%$118.72M0.11%Jun 30, 2026
Vanguard Total Stock Market Index Fund1,416,8172.54%$65.75M0.00%Jun 30, 2026
iShares Russell 2000 ETF1,186,7052.13%$55.07M0.07%Jun 30, 2026
Vanguard Small-Cap Index Fund1,021,2291.83%$47.40M0.03%Jun 30, 2026
Vanguard Small-Cap Growth Index Fund591,7841.06%$27.46M0.06%Jun 30, 2026
Fidelity Small Cap Index Fund499,0260.90%$17.75M0.05%Jul 31, 2026
Vanguard Extended Market Index Fund487,3180.87%$22.62M0.02%Jun 30, 2026
iShares Russell 2000 Growth ETF421,1710.76%$19.55M0.13%Jun 30, 2026
Diamond Hill Small Cap Fund411,9960.74%$19.12M6.21%Jun 30, 2026
Select Health Care Services Portfolio397,5900.71%$14.96M1.85%May 31, 2026
State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF390,0800.70%$18.10M0.11%Jun 30, 2026
iShares S&P Small-Cap 600 Value ETF365,4850.66%$16.96M0.21%Jun 30, 2026
Fidelity Small Cap Growth Fund318,5300.57%$11.33M0.13%Jul 31, 2026
Vanguard Tax-Managed Small-Cap Fund303,6920.54%$14.09M0.12%Jun 30, 2026
Fidelity Extended Market Index Fund223,5830.40%$8.41M0.02%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Kenneth T. SimExecutive Chairman, Director7,692,24213.80%Apr 8, 2026
John VongSVP - Accounting (PAO)21,1320.04%Nov 13, 2026
Brandon SimCEO and President1,880,6123.37%Oct 8, 2026
Chandan BashoCOO and CFO155,7280.28%Oct 6, 2026
Dinesh M. KumarChief Medical Officer177,6550.32%Apr 3, 2026
Thomas S. LamDirector7,729,54113.87%Oct 8, 2026
Mitchell W. KitayamaDirector24,3370.04%Sep 1, 2026
David SchmidtDirector56,0190.10%Aug 18, 2026
John ChiangDirector35,3730.06%Jun 12, 2026
Linda DongDirector97,1330.17%Jun 12, 2026
Matthew MazdyasniDirector39,2880.07%Jun 12, 2026
Dai, WeiliDirector18,1880.03%Jun 12, 2026
Glenn Sobotka–2,2460.00%Aug 11, 2026
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp10% owner6,132,80211.00%Feb 18, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
John Vong
SVP - Accounting (PAO)
Nov 12, 2026Tax withholding−642$31.77$20.40K21,132
John Vong
SVP - Accounting (PAO)
Oct 10, 2026Tax withholding−556$37.55$20.88K21,774
Brandon Sim
CEO and President
Oct 6, 2026Tax withholding−9,889$37.00$365.89K1,228,972
Thomas S. Lam
Director
Oct 6, 2026Tax withholding−2,624$37.00$97.09K463,033
Chandan Basho
COO and CFO
Oct 2, 2026Tax withholding−2,092$35.88$75.06K155,728
John Vong
SVP - Accounting (PAO)
Sep 15, 2026Tax withholding−96$38.35$3.68K22,330
Brandon Sim
CEO and President
Sep 5, 2026Tax withholding−7,163$38.47$275.56K1,238,861
Chandan Basho
COO and CFO
Sep 5, 2026Tax withholding−1,790$38.47$68.86K157,820
Mitchell W. Kitayama
Director
Aug 31, 2026Returned to company−8,500$37.09$315.27K24,337
David Schmidt
Director
Aug 14, 2026Option exercise+20,000$5.00$100.00K56,019
David Schmidt
Director
Aug 14, 2026Returned to company−20,000$38.59$771.80K36,019
Glenn Sobotka
–
Aug 7, 2026Returned to company−11,793––2,246
Brandon Sim
CEO and President
Jun 27, 2026Tax withholding−1,093$44.51$48.65K1,245,292
David Schmidt
Director
Jun 10, 2026Award+4,525––36,019
Dai, Weili
Director
Jun 10, 2026Award+4,525––18,188
Matthew Mazdyasni
Director
Jun 10, 2026Award+4,525––39,288
Mitchell W. Kitayama
Director
Jun 10, 2026Award+4,991––32,837
John Chiang
Director
Jun 10, 2026Award+4,525––35,373
Linda Dong
Director
Jun 10, 2026Award+4,525––97,133
Chandan Basho
COO and CFO
May 16, 2026Tax withholding−8,155$38.26$312.01K159,610
Chandan Basho
COO and CFO
Apr 14, 2026Tax withholding−3,870$29.07$112.50K167,765
Kenneth T. Sim
Executive Chairman, Director
Apr 6, 2026Award+100,000––739,407
Brandon Sim
CEO and President
Apr 6, 2026Award+201,056––1,246,385
Thomas S. Lam
Director
Apr 6, 2026Award+41,667––465,657
Chandan Basho
COO and CFO
Apr 2, 2026Tax withholding−2,092$25.05$52.40K171,635
Dinesh M. Kumar
Chief Medical Officer
Apr 1, 2026Tax withholding−57,980$24.51$1.42M177,655
Dinesh M. Kumar
Chief Medical Officer
Apr 1, 2026Award+35,300––235,635
Glenn Sobotka
Chief Accounting Officer
Mar 26, 2026Tax withholding−662$24.27$16.07K14,039
Dinesh M. Kumar
Chief Medical Officer
Mar 5, 2026Tax withholding−1,697$25.07$42.54K200,335
Chandan Basho
COO and CFO
Mar 5, 2026Tax withholding−1,240$25.07$31.09K173,727
Thomas S. Lam
Director
Mar 5, 2026Tax withholding−9,266$25.07$232.30K423,990
Brandon Sim
CEO and President
Feb 2, 2026Option exercise+21,334$23.24$495.80K1,045,329
Dinesh M. Kumar
Chief Medical Officer
Jan 23, 2026Tax withholding−10,759$27.16$292.21K202,032
David Schmidt
Director
Jan 13, 2026Option exercise+20,000$5.79$115.80K35,763
David Schmidt
Director
Jan 13, 2026Tax withholding−4,269$27.12$115.78K31,494
Dinesh M. Kumar
Chief Medical Officer
Jan 1, 2026Tax withholding−5,102$24.81$126.58K212,791
Thomas S. Lam
Director
Dec 8, 2025Tax withholding−25,866$22.00$569.05K433,256
Thomas S. Lam
Director
Dec 8, 2025Option exercise+29,502$17.78$524.55K459,122
Kenneth T. Sim
Executive Chairman, Director
Nov 10, 2025Option exercise+29,502$17.78$524.55K639,407
Matthew Mazdyasni
Director
Nov 10, 2025Option exercise+20,000$18.20$364.00K34,763
Mitchell W. Kitayama
Director
Nov 7, 2025Option exercise+12,000$18.20$218.40K27,846
Linda Dong
Director
Nov 3, 2025Option exercise+20,000$18.20$364.00K103,641
Linda Dong
Director
Nov 3, 2025Tax withholding−11,033$32.99$363.98K92,608
Chandan Basho
COO and CFO
Oct 2, 2025Tax withholding−1,979$27.77$54.96K174,967
Mitchell W. Kitayama
Director
Sep 15, 2025Returned to company−5,214$30.23$157.62K15,846
Mitchell W. Kitayama
Director
Sep 15, 2025Returned to company−8,000$30.23$241.84K21,060
Mitchell W. Kitayama
Director
Sep 15, 2025Option exercise+8,000$18.20$145.60K29,060
Chandan Basho
COO and CFO
Sep 5, 2025Tax withholding−1,694$29.70$50.31K176,946
Dinesh M. Kumar
Chief Medical Officer
Sep 5, 2025Tax withholding−1,694$29.70$50.31K217,893
David Schmidt
Director
Sep 2, 2025Returned to company−20,000$27.76$555.20K15,763
David Schmidt
Director
Sep 2, 2025Option exercise+20,000$18.20$364.00K35,763
John Chiang
Director
Aug 13, 2025Option exercise+20,000$18.20$364.00K43,132
John Chiang
Director
Aug 13, 2025Tax withholding−12,284$29.63$363.97K30,848
Dinesh M. Kumar
Chief Medical Officer
Jul 1, 2025Tax withholding−6,831$25.06$171.18K218,811
Linda Dong
Director
Jun 11, 2025Award+6,449––83,641
David Schmidt
Director
Jun 11, 2025Award+6,449––15,763
John Chiang
Director
Jun 11, 2025Award+6,449––23,132
Mitchell W. Kitayama
Director
Jun 11, 2025Award+6,449––21,060
Dai, Weili
Director
Jun 11, 2025Award+6,449––13,663
Matthew Mazdyasni
Director
Jun 11, 2025Award+6,449––14,763

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
7.75%
3M shares short
Days to cover
12.3
At 0M shares a day
Change since last report
-0.5%
From 3M shares
Short volume, 20 days
71.1%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Astrana Health's stock actually held short. Settlement fails (shares not delivered on time) peaked at 30,861 shares on Sep 16, 2026 over the last 90 days.

See a number that looks wrong?